RBC Sees 10-15% Move in Alexion Pharma (ALXN) Following ALXN-1210 Results

March 15, 2018 9:41 AM EDT Send to a Friend

RBC Capital analsyt Kennen MacKay was positive on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

RBC Sees 10-15% Move in Alexion Pharma (ALXN) Following ALXN-1210 Results

Member Login

Free News Feed